Course: All PhD that fits into one of the six key themes of the CSC.
Country: Bangladesh, Cameroon, Gambia, Kenya, Kiribati, Lesotho, Malawi, Mozambique, Nigeria, Pakistan, Rwanda, Sierra Leone, Solomon Islands, Tanzania, Tuvalu, Uganda, Vanuatu, Zambia
Value: Full tuition fee and living stipend.
No. of awards: Variable
Deadline: Commonwealth Scholarship applications are now closed.
Co-funded by Queen Mary and the UK Foreign, Commonwealth and Development Office (FCDO), Commonwealth PhD Scholarships enable talented and motivated individuals to gain the knowledge and skills required for sustainable development and are aimed at those who could not otherwise afford to study in the UK. These scholarships are offered under six themes:
To apply for these fellowships, you must:
Terms and conditions
Full eligibility criteria and general conditions of the award can be found on the CSC website
How to Apply
You must apply to one of the CSC's agreed nominating bodies in the first instance –the CSC does not accept direct applications for these scholarships. Please see their website for more information: https://cscuk.fcdo.gov.uk/scholarships/commonwealth-phd-scholarships-for-least-developed-countries-and-fragile-states/
You must then make your application using the CSC’s online application system, in addition to any other application that you are required to complete by your nominating body
You do not need to hold an unconditional offer in order to apply, however, you will need to include a supporting statement from your proposed supervisor.
Applications for Commonwealth PhD Scholarships (for least developed countries and fragile states) for the 2024/25 academic year are now closed.
For more information about funding opportunities available at Queen Mary, please contact Flora Mckay.
Please visit this CSC page for full guidance notes and the application link https://cscuk.fcdo.gov.uk/scholarships/commonwealth-phd-scholarships-for-least-developed-countries-and-fragile-states/
Faika Laz Banti, Commonwealth Scholar 2021/22, Bangladesh. PhD Barts Cancer Institute (Non-Clinical)
What one piece of advice would you give Commonwealth PhD applicants?
Commonwealth PhD scholarship is a very competitive scholarship. It’s important to prepare in advance. It's worth contacting your prospective supervisor or university early, as it will give you an opportunity to gain a deeper understanding of the proposed research and engage in scientific conversation. You will have time to reflect on the projects you are proposing. I will also recommend you ask yourself whether the program and supervisor are right for you.
The application process is very important for the selection criteria of the scholarship. In my case, my supervisor helped me a lot during my application process.
What made you choose the programme?
I did my undergraduate in Pharmacy and my masters in Cancer Sciences. I wanted to combine these two areas together and work on developing better treatment for cancer patients and Barts Cancer Institute was the perfect choice for me. Barts Cancer Institute (QMUL) is one of the leading cancer institute’s worldwide, conducting impactful and translational research that is generating significant improvements in early detection and diagnosis of different types of cancer, through the discovery and development of more effective and innovative therapies.
When I was searching for suitable projects, I found Professor Jude Fitzgibbon’s research on personalized epigenetic therapy in Acute Myeloid Leukemia very appealing. He has a strong track record of epigenetic research; well-funded and published and have excellent contacts with industry and the UK research network. Speaking with him and his team via zoom I was convinced that his lab would be ideal to complete a PhD programme.
What do you hope to do after you finish your studies?
I want to develop genomic-based personalized research for cancer patients in Bangladesh which will provide more accurate diagnoses and more effective treatments for not only cancer but also a wide range of diseases. With the overall aim of improving the morbidity and mortality of these patient groups.
Favourite aspect of the programme?
My favourite aspect of the programme is to work with a diverse group of people from multiple disciplines. This shows me how collaborative work can lead to creative and high impact research.